Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Int J Gynecol Cancer. 2011 Dec;21(9):1613–1621. doi: 10.1097/IGC.0b013e318228f6da

Figure 4.

Figure 4

Representative cytotoxicity experiments adding human serum (diluted 1:2) to hRS7 against EEC-ARK-1 cell line. The tumor cell line was treated with serum (with or without heat inactivation) in the presence or absence of the effector cells and hRS7 in a standard 5-hours 51Cr-release assays. Incubation with physiological concentrations of IgG (i.e., heat-inactivated (HI) serum diluted 1:2) to PBL in the presence of hRS7 did not significantly reduce the degree of ADCC achieved in the presence of hRS7 against EEC-ARK-1 (p= 0.773).